Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy.

Autor: Hirohata R; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Hamai Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Emi M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Ibuki Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Kurokawa T; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Ohsawa M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Kitasaki N; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.

Publikováno v: World journal of surgery [World J Surg] 2024 Jul; Vol. 48 (7), pp. 1700-1709. Date of Electronic Publication: 2024 May 17.

Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

Autor: Tanaka, Y., Takeuchi, H., Nakashima, Y., Nagano, H., Ueno, T., Tomizuka, K., Morita, S., Emi, Y., Hamai, Y., Hihara, J., Saeki, H., Oki, E., Kunisaki, C., Otsuji, E., Baba, H., Matsubara, H., Maehara, Y., Kitagawa, Y., Yoshida, K.

Publikováno v: In ESMO Open October 2021 6(5)

ASO Visual Abstract: Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy.

Autor: Hirohata R; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Yamamoto Y; Department of Cellular and Molecular Biology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Mimae T; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Hamai Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Ibuki Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Takahashi RU; Department of Cellular and Molecular Biology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan., Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Tahara H; Department of Cellular and Molecular Biology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. toshi@hiroshima-u.ac.jp.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.

Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone.

Autor: Ohsawa M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Hamai Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan. Electronic address: yyhamai@hiroshima-u.ac.jp., Emi M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Ibuki Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Kurokawa T; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Hirohata R; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Kitasaki N; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.

Publikováno v: Surgery [Surgery] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study.

Autor: Tsuji T; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan., Matsuda S; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan. s.matsuda.a8@keio.jp., Sato Y; Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan., Tanaka K; Graduate School of Medicine, Department of Gastroenterological Surgery, Osaka University, Suita, Japan., Sasaki K; Department of Surgical Oncology, Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University, Kagoshima, Japan., Watanabe M; Department of Gastroenterological Surgery, Shizuoka General Hospital, Shizuoka, Japan., Hamai Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan., Nasu M; Department of Esophageal and Gastroenterological Surgery, Juntendo University Hospital, Bunkyo, Japan., Saze Z; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, Fukushima, Japan., Nakashima Y; Department of Gastroenterological Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Nomura M; Department of Head and Neck Oncology and Innovative Treatment, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamamoto S; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Chuo, Japan., Booka E; Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan., Ishiyama K; Department of Esophageal Surgery, National Cancer Center Hospital, Chuo, Japan., Bamba T; Department of Gastroenterological Surgery, Niigata Cancer Center Hospital, Niigata, Japan., Sakanaka K; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tsushima T; Department of Gastroenterological Medicine, Shizuoka Cancer Center, Nagaizumi, Japan., Takeuchi H; Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan., Kato K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Chuo, Japan., Kawakubo H; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.